A gene therapy startup company
The startup headed up by bigwigs and backed early on by Atlas has pulled in a mega-round of $100 million. The 2-year-old startup captured investors’ attention by suggesting it knows a better way to do gene transfer.
Generation Bio is the Boston/Cambridge upstart. It’s a company that’s strayed from the pack when it comes to the how of gene therapy. While its rivals in the field are buckling down on viral vehicles like adeno associated viruses (AAV), Generation Bio is taking a different route.